Replimune Soars, Dell Surges, AST Spacemobile Sinks as Deutsche Bank Cuts on Rocket Explosion
On this episode of Stock Movers:- Replimune (REPL) shares soared after the company said US regulators would reconsider its skin cancer treatment after two prior rejections. The FDA will treat the review of Replimune's application "as an urgent matter" after the company said it has "aligned on a path forward" with the agency.- Dell (DELL) shares surged after the company gave an outlook for annual sales that far surpassed analysts’ estimates, fueled by demand for servers that power artificial intelligence work. Revenue in the fiscal year ending in January 2027 will be about $167 billion…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.